MEDP — Medpace Holdings Cashflow Statement
0.000.00%
Last trade - 00:00
- $11.53bn
- $11.28bn
- $1.89bn
- 99
- 18
- 98
- 83
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 100 | 145 | 182 | 245 | 283 |
Depreciation | |||||
Amortisation | |||||
Deferred Taxes | |||||
Non-Cash Items | 32.6 | 27 | 30.8 | 37.3 | 42.9 |
Other Non-Cash Items | |||||
Changes in Working Capital | 35.6 | 66.3 | 66.7 | 106 | 106 |
Change in Accounts Receivable | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Net Change in Other Assets & Liabilities | |||||
Cash from Operating Activities | 202 | 259 | 263 | 388 | 433 |
Capital Expenditures | -17.9 | -31.3 | -28.3 | -36.9 | -36.6 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -1.23 | 0.126 | -3.09 | -1.86 | 2.02 |
Other Investing Cash Flow | |||||
Cash from Investing Activities | -19.1 | -31.2 | -31.4 | -38.7 | -34.6 |
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -73.9 | -82.3 | -44.5 | -776 | -183 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 109 | 146 | 184 | -433 | 217 |